REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Steel City Pharmaceuticals Pvt Ltd (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Steel City Pharmaceuticals Pvt Ltd Profile Updated: May 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Steel City Pharmaceuticals Pvt Ltd is an unlisted company, incorporated on 28/12/1993. It has its registered office in the State of Andhra Pradesh LLP, India. Company's corporate identification number (CIN) is U24239AP1993PTC016799 and registration number is 016799. The company is a trade company, it is engaged in wholesale trading.

Legal Address
13-8-4/1,1St Floor, Steelcity Bhavan B.C. Road, New Gajuwaka
Visakhapatnam; Andhra Pradesh; Postal Code: 530026

Contact Details: Purchase the Steel City Pharmaceuticals Pvt Ltd report to view the information.

Basic Information
Outstanding Shares:
Purchase the Steel City Pharmaceuticals Pvt Ltd report to view the information.
Registered Capital:
Purchase the Steel City Pharmaceuticals Pvt Ltd report to view the information.
Incorporation Date:
December 28, 1993
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Independent Director
Company Performance
Financial values in the chart are available after Steel City Pharmaceuticals Pvt Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-5.81%▼
Total operating revenue
-5.86%▼
Operating profit (EBIT)
-7.1%▼
EBITDA
-8.12%▼
Net Profit (Loss) for the Period
-3.85%▼
Total assets
-3.56%▼
Total equity
21.68%▲
Operating Profit Margin (ROS)
-0.03%▼
Net Profit Margin
0.03%▲
Return on Equity (ROE)
-2.89%▼
Debt to Equity Ratio
-6.93%▼
Quick Ratio
0.25%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo